Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
IVD Medical Holding Limited ( (HK:1931) ) has issued an update.
ETHK Labs Inc. has scheduled a board meeting for 27 March 2026 to review and approve the group’s audited annual results for the financial year ended 31 December 2025. The board will also consider the declaration of a final dividend, if any, and address other corporate matters, signaling an upcoming disclosure of financial performance and potential shareholder returns for the year.
The announcement also restates the current composition of the board, listing three executive directors, two non-executive directors and three independent non-executive directors. This confirms the company’s governance lineup as it approaches a key financial reporting date, providing investors with clarity on oversight ahead of the release of the 2025 annual results.
The most recent analyst rating on (HK:1931) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on IVD Medical Holding Limited stock, see the HK:1931 Stock Forecast page.
More about IVD Medical Holding Limited
ETHK Labs Inc., formerly known as IVD Medical Holding Limited, is a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange. The group operates through a board comprising executive, non-executive and independent non-executive directors, reflecting a standard governance structure for a Hong Kong-listed corporate issuer.
Average Trading Volume: 4,698,216
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.95B
See more insights into 1931 stock on TipRanks’ Stock Analysis page.